Cyclosporine-associated thrombotic microangiopathy during daclizumab induction: a suggested therapeutic approach. [electronic resource]
Producer: 20010621Description: 361-4 p. digitalISSN:- 1660-8151
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Biomarkers -- blood
- Blood Component Transfusion
- Cyclosporine -- adverse effects
- Daclizumab
- Drug Therapy, Combination
- Female
- Fibrin Fibrinogen Degradation Products -- analysis
- Hemolysis
- Humans
- Immunoglobulin G -- therapeutic use
- Immunosuppressive Agents -- adverse effects
- Kidney Failure, Chronic -- etiology
- Kidney Transplantation -- immunology
- Living Donors
- Male
- Microcirculation -- pathology
- Middle Aged
- Plasmapheresis
- Polycystic Kidney Diseases -- complications
- Tacrolimus -- therapeutic use
- Thrombosis -- chemically induced
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.